Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998).
暂无分享,去创建一个
Ronald N. Jones | R N Jones | W W Wilke | M. Pfaller | G. Doern | R. Jones | A. Gales | H. Sader | M A Pfaller | W. Wilke | M. Beach | A C Gales | K A Gordon | H S Sader | M L Beach | G V Doern | W. W. Wilke | K. A. Gordon
[1] E. Bruck,et al. National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.
[2] K. Thomson,et al. USA resistance patterns among UTI pathogens. , 1994, The Journal of antimicrobial chemotherapy.
[3] R. Wenzel,et al. Urinary tract etiology of bloodstream infections in hospitalized patients. , 1983, The Journal of infectious diseases.
[4] D. Hooper,et al. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations , 1995, Antimicrobial agents and chemotherapy.
[5] D. Hooper,et al. Sequential mutations of gyrA in Escherichia coli associated with quinolone therapy. , 1995, The Journal of antimicrobial chemotherapy.
[6] R. Cluzel,et al. Nucleotide sequences of CAZ-2, CAZ-6, and CAZ-7 beta-lactamase genes , 1992, Antimicrobial Agents and Chemotherapy.
[7] Ronald N. Jones,et al. Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997) , 1998, Antimicrobial Agents and Chemotherapy.
[8] R. Wenzel,et al. Comparative evaluation of an automated ribotyping system versus pulsed-field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent gram-negative bacteremia. , 1996, Diagnostic microbiology and infectious disease.
[9] G. Jacoby,et al. Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases , 1990, Antimicrobial Agents and Chemotherapy.
[10] D. Stephens,et al. Urinary tract infection: an overview. , 1997, The American journal of the medical sciences.
[11] F. Goldstein,et al. Trends in bacterial resistance to fluoroquinolones. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] M. Georgiou,et al. Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC , 1996, Antimicrobial agents and chemotherapy.
[13] G. Jacoby,et al. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins , 1996, Antimicrobial agents and chemotherapy.
[14] D. Livermore,et al. Plasmid-mediated production of class I (AmpC) beta-lactamase by two Klebsiella pneumoniae isolates from the UK. , 1995, The Journal of antimicrobial chemotherapy.
[15] B. Rosner,et al. Mortality associated with nosocomial urinary-tract infection. , 1982, The New England journal of medicine.
[16] C. Bizet,et al. In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase. , 1989, The Journal of infectious diseases.
[17] R. Jones. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. , 1996, The American journal of medicine.
[18] R. Jones,et al. Automation of polymerase chain reaction tests to achieve acceptable contamination rates. , 1995, Clinical chemistry.
[19] Nnis System,et al. National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System. , 1999, American journal of infection control.
[20] National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. , 1996, American journal of infection control.
[21] R. Wenzel,et al. Secular trends in rates and etiology of nosocomial urinary tract infections at a university hospital. , 1993, The Journal of urology.
[22] M. Pfaller,et al. Use of macrorestriction analysis to demonstrate interhospital spread of multiresistant Acinetobacter baumannii in São Paulo, Brazil. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] G. Jacoby,et al. A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.
[24] H. Neu. Urinary tract infections. , 1992, The American journal of medicine.
[25] J W Warren,et al. Catheter-associated urinary tract infections. , 1997, International journal of antimicrobial agents.
[26] P. Taillon-Miller,et al. PCR buffer optimization with uniform temperature regimen to facilitate automation. , 1993, PCR methods and applications.
[27] W. Stamm,et al. Urinary tract infections in women: diagnosis and treatment. , 1989, Annals of internal medicine.
[28] Ronald N. Jones,et al. Antimicrobial susceptibility of bacteria causing urinary tract infections in Latin American hospitals: results from the SENTRY Antimicrobial Surveillance Program (1997). , 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[29] M. Cormican,et al. Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen , 1996, Journal of clinical microbiology.